Home | By sponsor

CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title Date of Registration State
CENTAURO Study 2011-04-29 Registered
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months. 2011-04-29 Registered
Alum Phospate Adjuvated QuimiHib® Vaccine Clinical Study. 2011-04-28 Registered
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks. 2011-04-27 Registered
InCarbacel-II 2010-12-28 Registered
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed 2010-12-27 Registered
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers. 2010-12-24 Registered
Clinical trial, phase II, to evaluate rhEGF efficacy and safety at a dose of 25 or 75 micrograms intralesionally in patients with diabetic foot ulcer (Wagner grade 1 or 2). 2010-12-24 Registered
InCCNM -I 2010-12-24 Registered
Application of CIGB-128 in keloid patients undergoing surgical exeresis. 2010-12-24 Registered
CIGB-128 administration to patients with surgically-treated keloids. 2010-12-24 Registered
CIGB500 in healthy volunteers 2010-12-20 Registered
THERESA-2 Study 2010-12-20 Registered
Dynamic-I 2010-12-20 Registered
Dermosep-I 2010-12-20 Registered
EPANEM-III 2010-12-20 Registered
AntiCEA M3-I 2010-12-20 Registered
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency. 2010-09-27 Registered
Phase I clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. 2010-06-11 Registered
InCroMiel I 2009-12-24 Registered